NGBideas S4.E7 - Providence Therapeutics episode artwork

EPISODE · Jul 7, 2026 · 1H 47M

NGBideas S4.E7 - Providence Therapeutics

from NGBideas · host Jim Wilson

Based in Calgary, Alberta, Providence Therapeutics is a Canadian mRNA company focused on personalized cancer vaccines. During the pandemic, Brad Sorenson and his team developed a COVID vaccine that went head to head against Pfizer in clinical trials and held its own, yet almost no one in Canada ever heard about it.In this episode, host Jim Wilson speaks with founder and CEO Brad Sorenson about a journey that is as personal as it is professional. In 2013, Brad's 13-year-old son Adam was diagnosed with glioblastoma and given a year to live. Thirteen years later, Adam is still here, and Brad walks through the extraordinary series of events that shaped both his son's survival and the company he built.It is also a candid conversation about the realities of drug development in Canada and Brad's passionate call for the country to give patients the right to fight for their lives through compassionate access.

Episode metadata supplied by the publisher feed · Published Jul 7, 2026

Embed this episode

Ready to play

NGBideas S4.E7 - Providence Therapeutics

0:00 1:47:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of NGBideas?

This episode is 1 hour and 47 minutes long.

When was this NGBideas episode published?

This episode was published on July 7, 2026.

Can I download this NGBideas episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!